1. A randomized comparison of idarubicin vs mitoxantrone, in association to VP-16 and cytarabine for induction/consolidation therapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia (AML);Archimbaud;British Journal of Haematology,1996
2. Archimbaud E Jehn U Thomas X De Cataldo F Fillet G Belhabri A Idarubicin versus mitoxantrone, in association with VP-16 and ARAC for induction/consolidation therapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia. Final analysis of a randomized trial [abstract] Journal of Clinical Onclogy 1997 3a
3. Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia;Archimbaud;Leukemia,1999
4. Cataldo F Martin C Thomas X Idarubicin or mitoxantrone, VP-16 and cytarabine for induction/consolidation therapy followed by autologous stem cell transplantation in elderly patients with acute myeloid leukemia (AML): a feasibility study Annals of Hematology 1995 a136
5. Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia;Beksac;Medical Oncology,1998